Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.

Identifieur interne : 000028 ( Main/Exploration ); précédent : 000027; suivant : 000029

Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.

Auteurs : Sergi Hernández [Oman] ; Carmen Mu Oz-Almagro [Espagne] ; Pilar Ciruela [Espagne] ; Núria Soldevila [Espagne] ; Conchita Izquierdo [Espagne] ; Maria Gemma Codina [Espagne] ; Alvaro Díaz [Espagne] ; Fernando Moraga-Llop [Espagne] ; Juan José García-García [Espagne] ; Ángela Domínguez [Espagne]

Source :

RBID : pubmed:31189583

Descripteurs français

English descriptors

Abstract

The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of Streptococcus pneumoniae by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ2 test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55; P < 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47; P < 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77; P = 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29; P = 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.

DOI: 10.1128/JCM.00363-19
PubMed: 31189583
PubMed Central: PMC6663900


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</title>
<author>
<name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author>
<name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital de Nens, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital de Nens, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31189583</idno>
<idno type="pmid">31189583</idno>
<idno type="doi">10.1128/JCM.00363-19</idno>
<idno type="pmc">PMC6663900</idno>
<idno type="wicri:Area/Main/Corpus">00014</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00014</idno>
<idno type="wicri:Area/Main/Curation">000014</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000014</idno>
<idno type="wicri:Area/Main/Exploration">000014</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</title>
<author>
<name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author>
<name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<affiliation wicri:level="3">
<nlm:affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital de Nens, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital de Nens, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Universitari Vall d'Hebron, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat</wicri:regionArea>
<wicri:noRegion>Esplugues de Llobregat</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
</author>
<author>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departament de Medicina, Universitat de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
<orgName type="university">Université de Barcelone</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of clinical microbiology</title>
<idno type="eISSN">1098-660X</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Female (MeSH)</term>
<term>Hospitalization (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Male (MeSH)</term>
<term>Pandemics (statistics & numerical data)</term>
<term>Pneumococcal Infections (epidemiology)</term>
<term>Pneumococcal Infections (microbiology)</term>
<term>Pneumococcal Infections (prevention & control)</term>
<term>Pneumococcal Vaccines (administration & dosage)</term>
<term>Prospective Studies (MeSH)</term>
<term>Serogroup (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Streptococcus pneumoniae (genetics)</term>
<term>Vaccination Coverage (statistics & numerical data)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Couverture vaccinale (statistiques et données numériques)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Incidence (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Infections à pneumocoques (microbiologie)</term>
<term>Infections à pneumocoques (prévention et contrôle)</term>
<term>Infections à pneumocoques (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Pandémies (statistiques et données numériques)</term>
<term>Streptococcus pneumoniae (génétique)</term>
<term>Sérogroupe (MeSH)</term>
<term>Vaccins antipneumococciques (administration et posologie)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Pneumococcal Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antipneumococciques</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Streptococcus pneumoniae</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Pneumococcal Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Pandemics</term>
<term>Vaccination Coverage</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Couverture vaccinale</term>
<term>Pandémies</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
<term>Infections à pneumocoques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Incidence</term>
<term>Infant</term>
<term>Male</term>
<term>Prospective Studies</term>
<term>Serogroup</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Incidence</term>
<term>Indice de gravité de la maladie</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Sérogroupe</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of
<i>Streptococcus pneumoniae</i>
by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ
<sup>2</sup>
test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55;
<i>P</i>
< 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47;
<i>P</i>
< 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77;
<i>P</i>
= 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29;
<i>P</i>
= 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">31189583</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>07</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>07</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Electronic-Print">
<Journal>
<ISSN IssnType="Electronic">1098-660X</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>57</Volume>
<Issue>8</Issue>
<PubDate>
<Year>2019</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Journal of clinical microbiology</Title>
<ISOAbbreviation>J. Clin. Microbiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e00363-19</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00363-19</ELocationID>
<Abstract>
<AbstractText>The objective of this study was to analyze the incidence, clinical presentation, and severity of invasive pneumococcal disease (IPD)-causing serotypes and the impact of the 13-valent pneumococcal conjugate vaccination during epidemic and nonepidemic influenza periods in Catalonia, Spain. This was a prospective study in persons aged <18 years diagnosed with IPD between 2012 and 2015 in three Catalan pediatric hospitals. IPD was defined as clinical infection together with isolation of
<i>Streptococcus pneumoniae</i>
by culture and/or detection by reverse transcription-PCR in a normally sterile sample. Incidence rate ratios (IRRs) and the fraction of IPD prevented associated with 13-valent pneumococcal conjugate vaccine (PCV13) were calculated. The bivariate analysis used the χ
<sup>2</sup>
test and the multivariate analysis nonconditional logistic regression. A total of 229 cases of IPD were recorded. The incidence was higher during influenza epidemic periods (IRR, 2.7; 95% confidence interval [CI], 2.05 to 3.55;
<i>P</i>
< 0.001), especially for pneumonia (IRR, 3.25; 95% CI, 2.36 to 4.47;
<i>P</i>
< 0.001), with no differences in the distribution of pneumococcal serotypes. Complications during admission and sequel at discharge were greater during epidemic periods (adjusted odds ratio [aOR], 2.00; 95% CI, 1.06 to 3.77;
<i>P</i>
= 0.03) than at nonepidemic periods (aOR, 3.38; 95% CI, 1.37 to 8.29;
<i>P</i>
= 0.01). The prevented fraction for the population (PFp) of IPD in children aged 7 to 59 months was 48% to 49.4%. The PFp was higher in influenza epidemic than nonepidemic periods and increased when ≥2 doses of PCV13 or ≥1 after 24 months were administered. Influenza virus circulation increases the incidence of IPD in persons aged <18 years. In influenza epidemic periods, IPD cases were more severe. Increased PCV13 coverage might increase the fraction of IPD prevented in epidemic and nonepidemic periods.</AbstractText>
<CopyrightInformation>Copyright © 2019 American Society for Microbiology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hernández</LastName>
<ForeName>Sergi</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-0461-6190</Identifier>
<AffiliationInfo>
<Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain hernandez.sergi@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muñoz-Almagro</LastName>
<ForeName>Carmen</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Departament de Medicina, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ciruela</LastName>
<ForeName>Pilar</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Soldevila</LastName>
<ForeName>Núria</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Izquierdo</LastName>
<ForeName>Conchita</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Agència de Salut Pública de Catalunya, Generalitat de Catalunya, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Codina</LastName>
<ForeName>Maria Gemma</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Díaz</LastName>
<ForeName>Alvaro</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Hospital de Nens, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Moraga-Llop</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Hospital Universitari Vall d'Hebron, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>García-García</LastName>
<ForeName>Juan José</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo>
<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Malalties Prevenibles amb Vacunes, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Hospital Sant Joan de Déu Barcelona, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Domínguez</LastName>
<ForeName>Ángela</ForeName>
<Initials>Á</Initials>
<AffiliationInfo>
<Affiliation>Departament de Medicina, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Clin Microbiol</MedlineTA>
<NlmUniqueID>7505564</NlmUniqueID>
<ISSNLinking>0095-1137</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C538862">13-valent pneumococcal vaccine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D022242">Pneumococcal Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022242" MajorTopicYN="N">Pneumococcal Vaccines</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">13-valent pneumococcal conjugate vaccine</Keyword>
<Keyword MajorTopicYN="Y">highly invasive serotypes</Keyword>
<Keyword MajorTopicYN="Y">influenza virus</Keyword>
<Keyword MajorTopicYN="Y">invasive pneumococcal disease</Keyword>
<Keyword MajorTopicYN="Y">seasonality</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>03</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>6</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31189583</ArticleId>
<ArticleId IdType="pii">JCM.00363-19</ArticleId>
<ArticleId IdType="doi">10.1128/JCM.00363-19</ArticleId>
<ArticleId IdType="pmc">PMC6663900</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2004 Oct 1;190(7):1203-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15346329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Feb;80(4):1629-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16439519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2006 Sep 1;194(5):682-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16897668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatrics. 2008 Aug;122(2):229-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18676537</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2008 Sep;14(9):828-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18844683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Dec 31;4(12):e8540</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20046873</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2010 Oct;29(10):905-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20407400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2010 Oct 15;202(8):1287-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20822454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2012 Feb 1;205(3):458-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22158564</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2012 Feb;31(2):124-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22173137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2012 Feb;18(2):208-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22306234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2012 Jun;31(6):650-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22333697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2012 Nov;50(11):3451-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22875895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2013 Apr;207(7):1135-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23303809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2013 Jun;66(6):512-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23473714</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2013 May 21;13:229</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23687999</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2013 Oct 15;208(8):1274-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23901093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2014 Mar;43(3):833-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24036243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2013 Dec 16;31(52):6232-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24176490</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 Jan;58(2):188-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24190895</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2014 Jul;20(7):684-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24467648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2014 May;58(10):1369-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24621951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2014 May;33(5):504-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24670957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2014 Dec;20(12):O1088-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24977322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):705-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25413925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2015 Jan 06;12(1):e1001776</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25562317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2015 May 1;60(9):1384-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25595749</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Rep. 2015 Sep;16(9):1203-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26265006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Public Health. 2016 May 13;16:400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27178436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2016 Aug 31;34(38):4565-4571</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27473304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Oct 4;11(10):e0163889</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27701435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Rep. 2016 Dec 06;6:38532</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27922126</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Aug 14;12(8):e0183191</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28806737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 1996 Jan;22(1):100-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8824973</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
<li>Oman</li>
</country>
<region>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Madrid</li>
</settlement>
<orgName>
<li>Université de Barcelone</li>
</orgName>
</list>
<tree>
<country name="Oman">
<region name="Catalogne">
<name sortKey="Hernandez, Sergi" sort="Hernandez, Sergi" uniqKey="Hernandez S" first="Sergi" last="Hernández">Sergi Hernández</name>
</region>
</country>
<country name="Espagne">
<region name="Communauté de Madrid">
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
</region>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<name sortKey="Ciruela, Pilar" sort="Ciruela, Pilar" uniqKey="Ciruela P" first="Pilar" last="Ciruela">Pilar Ciruela</name>
<name sortKey="Codina, Maria Gemma" sort="Codina, Maria Gemma" uniqKey="Codina M" first="Maria Gemma" last="Codina">Maria Gemma Codina</name>
<name sortKey="Diaz, Alvaro" sort="Diaz, Alvaro" uniqKey="Diaz A" first="Alvaro" last="Díaz">Alvaro Díaz</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Garcia Garcia, Juan Jose" sort="Garcia Garcia, Juan Jose" uniqKey="Garcia Garcia J" first="Juan José" last="García-García">Juan José García-García</name>
<name sortKey="Izquierdo, Conchita" sort="Izquierdo, Conchita" uniqKey="Izquierdo C" first="Conchita" last="Izquierdo">Conchita Izquierdo</name>
<name sortKey="Moraga Llop, Fernando" sort="Moraga Llop, Fernando" uniqKey="Moraga Llop F" first="Fernando" last="Moraga-Llop">Fernando Moraga-Llop</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Mu Oz Almagro, Carmen" sort="Mu Oz Almagro, Carmen" uniqKey="Mu Oz Almagro C" first="Carmen" last="Mu Oz-Almagro">Carmen Mu Oz-Almagro</name>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
<name sortKey="Soldevila, Nuria" sort="Soldevila, Nuria" uniqKey="Soldevila N" first="Núria" last="Soldevila">Núria Soldevila</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000028 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000028 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31189583
   |texte=   Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31189583" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021